Internet Archive Scholar

COVID-19 Outcome Prediction by Integrating Clinical and Metabolic Data using Machine Learning Algorithms

Karen E Villagrana-Bañuelos, Valeria Maeda-Gutiérrez, Vanessa Alcalá-Rmz, Juan J Oropeza-Valdez, Ana S Herrera-Van Oostdam, Julio E Castañeda-Delgado, Jesús Adrián López, Juan C Borrego Moreno, Carlos E Galván-Tejada, Jorge I Galván-Tejeda, Hamurabi Gamboa-Rosales, Huizilopoztli Luna-García (+2 others)
2022

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (1.3 MB)
https://web.archive.org/web/20221224152121/https://clinicalandtranslationalinvestigation.com/files/ric_22_74_6_314-327.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

The coronavirus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and is responsible for nearly 6 million deaths worldwide in the past 2 years. Machine learning (ML) models could help physicians in identifying high-risk individuals. To study the use of ML models for COVID-19 prediction outcomes using clinical data and a combination of clinical and metabolic data, measured in a metabolomics facility from a public university. A total of 154 patients were included in the
more » ... udy. "Basic profile" was considered with clinical and demographic variables (33 variables), whereas in the "extended profile," metabolomic and immunological variables were also considered (156 characteristics). A selection of features was carried out for each of the profiles with a genetic algorithm (GA) and random forest models were trained and tested to predict each of the stages of COVID-19. The model based on extended profile was more useful in early stages of the disease. Models based on clinical data were preferred for predicting severe and critical illness and death. ML detected trimethylamine N-oxide, lipid mediators, and neutrophil/lymphocyte ratio as important variables. ML and GAs provided adequate models to predict COVID-19 outcomes in patients with different severity grades.
doi:10.24875/ric.22000182 pmid:36546894 fatcat:m5ukvqovrbcvxarpyaccrv25xi
Citation

Karen E Villagrana-Bañuelos, Valeria Maeda-Gutiérrez, Vanessa Alcalá-Rmz, Juan J Oropeza-Valdez, Ana S Herrera-Van Oostdam, Julio E Castañeda-Delgado, Jesús Adrián López, Juan C Borrego Moreno, Carlos E Galván-Tejada, Jorge I Galván-Tejeda, Hamurabi Gamboa-Rosales, Huizilopoztli Luna-García, José M Celaya-Padilla, Yamilé López-Hernández. "COVID-19 Outcome Prediction by Integrating Clinical and Metabolic Data using Machine Learning Algorithms." (2022) 314-327